Audiogenic Seizures in the Fmr1 Knockout Mouse Are Induced By

Total Page:16

File Type:pdf, Size:1020Kb

Audiogenic Seizures in the Fmr1 Knockout Mouse Are Induced By Research Articles: Neurobiology of Disease Audiogenic seizures in the Fmr1 knockout mouse are induced by Fmr1 deletion in subcortical, vGlut2-expressing excitatory neurons and require deletion in the Inferior Colliculus https://doi.org/10.1523/JNEUROSCI.0886-19.2019 Cite as: J. Neurosci 2019; 10.1523/JNEUROSCI.0886-19.2019 Received: 24 April 2019 Revised: 6 September 2019 Accepted: 16 October 2019 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2019 the authors 1 Audiogenic seizures in the Fmr1 knockout mouse are induced by Fmr1 deletion in subcortical, 2 vGlut2-expressing excitatory neurons and require deletion in the Inferior Colliculus 3 4 Authors: 5 Darya Gonzalez1, Madison Tomasek1, Seth Hays1, Vinay Sridhar1, Simon Ammanuel1, Chia-wei Chang1, 6 Karen Pawlowski2, Kimberly M. Huber*1, Jay R. Gibson*1. 7 *co-authors 8 1University of Texas Southwestern Medical Center at Dallas, Department of Neuroscience, Dallas, TX 9 75390-9111, USA 10 2University of Texas Southwestern Medical Center at Dallas, Department of Otolaryngology and 11 Biomedical Engineering Program, Dallas, TX 75390-9035, USA 12 13 14 Abbreviated Title: Circuits for audiogenic seizures in Fmr1 knockout (49 char, 50 char max) 15 16 Corresponding Authors: 17 Jay R. Gibson, Kimberly Huber 18 University of Texas, Southwestern Medical Center 19 Department of Neuroscience, Box 9111 20 Dallas, TX 75390-9111 21 Phone: 214-648-5133, Fax: 214-648-1801, Email: [email protected] 22 Phone: 214-648-5134, Fax: 214-648-1801, Email: [email protected] 23 24 Author Contributions 25 JRG, KMH, planned and designed experiments. DG, MT, SH, VS, SA, CWC, KP, and JRG performed 26 experiments and analyzed data. JRG and KMH prepared the manuscript. 1 28 27 pages, 7 figures; Words: title=24 (50), Abstract=247 (250), Introduction=655 (650), Sig. Statement 29 =107 (120), Results=2150, Discussion=1515 (1500). 30 Acknowledgements: We thank Patricia Hahn, Bianca Walker, and Manasa Sarma for technical 31 assistance. We thank the Neuroscience Microscopy Facility for use of confocal microscopes. This facility 32 is supported by the University of Texas, Southwestern Neuroscience department and the Peter O’Donnell 33 Jr. Brain Institute. KP is now affiliated with University of Texas at Dallas, School of Behavioral and 34 Brain Sciences. SH is now affiliated with University of Texas at Dallas, Department of Bioengineering. 35 Funding: NIH funding from NICHD, 1U54HD082008-01 (JRG, KMH) 36 37 38 3 39 Abstract 40 Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading 41 monogenetic cause of autism. One symptom of FXS and autism is sensory hypersensitivity (also called 42 sensory over-responsivity). Perhaps related to this, the audiogenic seizure (AGS) is arguably the most 43 robust behavioral phenotype in the FXS mouse model - the Fmr1 knockout (KO) mouse. Therefore, the 44 AGS may be considered a mouse model of sensory hypersensitivity. Hyperactive circuits are 45 hypothesized to underlie dysfunction in a number of brain regions in FXS patients and Fmr1 KO mice, 46 and the AGS may be a result of this. But the specific cell-types and brain regions underlying AGSs in the 47 Fmr1 KO are unknown. We used conditional deletion or expression of Fmr1 in different cell populations 48 to determine whether Fmr1 deletion in those cells was sufficient or necessary, respectively, for the AGS 49 phenotype in males. Our data indicate that Fmr1 deletion in glutamatergic neurons that express vesicular 50 glutamate transporter 2 (vGlut2) and located in subcortical brain regions is sufficient and necessary to 51 cause AGSs. Furthermore, deletion of Fmr1 in glutamatergic neurons of the inferior colliculus is 52 necessary for AGSs. When we demonstrate necessity, we show that Fmr1 expression in either the larger 53 population of vGlut2-expressing glutamatergic neurons or the smaller population of inferior collicular 54 glutamatergic neurons - in an otherwise Fmr1 KO mouse - eliminates AGSs. Therefore, targeting these 55 neuronal populations in FXS and autism may be part of a therapeutic strategy to alleviate sensory 56 hypersensitivity. 57 58 Significance 59 Sensory hypersensitivity in Fragile X syndrome (FXS) and autism patients significantly interferes with 60 quality of life. Audiogenic seizures (AGSs) are arguably the most robust behavioral phenotype in the 61 FXS mouse model – the Fmr1 knockout - and may be considered a model of sensory hypersensitivity in 62 FXS. We provide the clearest and most precise genetic evidence to date for the cell-types and brain 63 regions involved in causing AGSs in the Fmr1 knockout, and more broadly, for any mouse mutant. 64 Expression of Fmr1 in these same cell-types in an otherwise Fmr1 knockout eliminates AGSs indicating 65 possible cellular targets for alleviating sensory hypersensitivity in FXS and other forms of autism. 4 66 Introduction 67 68 Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading 69 monogenetic cause of autism (Bassell and Warren, 2008). It is caused by loss of function mutations in 70 FMR1 which encodes an RNA binding protein, FMRP. Many of the impairments in FXS are reproduced 71 in the FXS mouse model, the Fmr1 knockout (KO) mouse (Bakker, 1994). 72 Sensory hypersensitivity (or sensory over-responsivity) and abnormal sensory processing occur in 70- 73 90% of FXS and autistic patients, and these traits can significantly disrupt behavior (Musumeci et al., 74 1994, Miller et al., 1999, Rojas et al., 2001, Baranek et al., 2008, Ben-Sasson et al., 2009, Hagerman et 75 al., 2009). FXS patients display increased physiological auditory responses as observed by the event- 76 related potential (ERP) amplitude and reduced habituation of the ERP in response to repeated sounds 77 (Castren et al., 2003, Van der Molen et al., 2011, Ethridge et al., 2016). These ERP changes correlate 78 with sensory hypersensitivity and communication deficits in FXS patients, suggesting that 79 hyperexcitability of auditory pathways contribute to these symptoms (Ethridge et al., 2016). Fmr1 KO 80 mice also have an enhanced auditory ERP in the form of reduced habituation and enhanced sound-evoked 81 firing of auditory cortical neurons (Rotschafer and Razak, 2013). The mice also have audiogenic 82 seizures (AGSs) (Musumeci et al., 2000, Chen and Toth, 2001). 83 As a result of these and other observations, it is hypothesized that brain circuits are hyperexcitable in FXS 84 (Contractor et al., 2015). In support of this idea, individuals with FXS have an increased incidence of 85 epilepsy (Musumeci et al., 1999, Sabaratnam et al., 2001, Berry-Kravis et al., 2010). Indeed, in the Fmr1 86 KO mouse, circuit hyperexcitability and potential underlying mechanisms have been well demonstrated in 87 neocortex and hippocampus (Chuang et al., 2005, Galvez and Greenough, 2005, Goncalves et al., 2013, 88 Cea-Del Rio and Huntsman, 2014, Zhang et al., 2014a, Contractor et al., 2015). However, establishing a 89 link between a specific hyperexcitable circuit and altered behavior in the Fmr1 KO mouse has been 90 elusive. 91 We consider the AGS in the Fmr1 KO mice to be a model of sensory stimulus hypersensitivity in FXS. 92 AGSs occur in other autism mouse models, such as with Syngap1 and Ube3a deletion (Jiang et al., 1998, 93 Clement et al., 2012). The AGS is arguably the most robust behavioral phenotype in the Fmr1 KO mouse 94 and has been reproduced in 49 original research articles since 2000 and in multiple strain backgrounds 95 (Table I). But interpretations from all these studies are limited by lack of knowledge of the circuits or 96 cell-types in which Fmr1 functions to cause the AGS. 5 97 From studies of seizure-prone rat and mouse strains, AGSs likely originate from hyperexcitable circuits in 98 the brain stem (Faingold, 2002, 2004, Ribak, 2015). In the Fmr1 KO, studies using c-fos expression to 99 mark active neurons during the AGS implicate cells in the midbrain and pons (Chen and Toth, 2001), but 100 this experimental approach cannot determine if FMRP deletion in these active neurons causes the AGS or 101 if they are simply indirectly activated. 102 By crossing mice with conditional deletion or expression of Fmr1 with cell type and/or brain region 103 specific Cre lines, we determined the locus in which Fmr1 deletion causes AGSs. Fmr1 is expressed in 104 many cell types throughout the brain: neurons, astrocytes, oligodendrocytes, and endothelial cells (Zhang 105 et al., 2014b). Our results indicate that Fmr1 deletion in subcortical glutamatergic neurons that express 106 vesicular glutamate transporter 2 (vGlut2) underlies AGSs. Fmr1 deletion in glutamatergic neurons in the 107 inferior colliculus is necessary for the phenotype, which represents the most precise genetic localization 108 to date for causing AGS in mice. This latter finding pertaining to the inferior colliculus implicates a 109 potentially hyperexcitable, localized circuit underlying a behavioral phenotype in the Fmr1 KO mouse. 110 Finally, selective Fmr1 expression in glutamatergic neurons in an otherwise Fmr1 KO mouse eliminates 111 AGSs suggesting that targeting these neurons may be part of a strategy to alleviate sensory 112 hypersensitivity in FXS and in autism. 113 114 Materials and Methods 115 116 Mice 117 For conditional Fmr1 deletion, experimental mice were produced by crossing a sire expressing Cre- 118 recombinase (Cre) in a specific neuronal population to an Fmr1loxP/+ dam (Mientjes et al., 2006). We refer 119 to the loxP allele as “conditional off”, or cOFF, and the genotype as Fmr1cOFF/+.
Recommended publications
  • Genetic and Neurodevelopmental Spectrum Of
    Cognitive and behavioural genetics J Med Genet: first published as 10.1136/jmedgenet-2015-103451 on 17 March 2016. Downloaded from ORIGINAL ARTICLE Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy Cyril Mignot,1,2,3 Celina von Stülpnagel,4,5 Caroline Nava,1,6 Dorothée Ville,7 Damien Sanlaville,8,9,10 Gaetan Lesca,8,9,10 Agnès Rastetter,6 Benoit Gachet,6 Yannick Marie,6 G Christoph Korenke,11 Ingo Borggraefe,12 Dorota Hoffmann-Zacharska,13 Elżbieta Szczepanik,14 Mariola Rudzka-Dybała,14 Uluç Yiş,15 Hande Çağlayan,16 Arnaud Isapof,17 Isabelle Marey,1 Eleni Panagiotakaki,18 Christian Korff,19 Eva Rossier,20 Angelika Riess,21 Stefanie Beck-Woedl,21 Anita Rauch,22 Christiane Zweier,23 Juliane Hoyer,23 André Reis,23 Mikhail Mironov,24 Maria Bobylova,24 Konstantin Mukhin,24 Laura Hernandez-Hernandez,25 Bridget Maher,25 Sanjay Sisodiya,25 Marius Kuhn,26 Dieter Glaeser,26 Sarah Weckhuysen,6,27 Candace T Myers,28 Heather C Mefford,28 Konstanze Hörtnagel,29 Saskia Biskup,29 EuroEPINOMICS-RES MAE working group, Johannes R Lemke,30 Delphine Héron,1,2,3,4 Gerhard Kluger,4,5 Christel Depienne1,6 ▸ Additional material is ABSTRACT INTRODUCTION published online only. To view Objective We aimed to delineate the neurodevelopmental The human SYNGAP1 gene on chromosome please visit the journal online (http://dx.doi.org/10.1136/ spectrum associated with SYNGAP1 mutations and to 6p21.3 encodes the synaptic RAS-GTPase-activating jmedgenet-2015-103451). investigate genotype–phenotype correlations. protein 1, a protein of the post-synaptic density Methods We sequenced the exome or screened the exons (PSD) of glutamatergic neurons.12SYNGAP1 inter- For numbered affiliations see end of article.
    [Show full text]
  • Translational Regulation of Syngap1 by FMRP Modulates NMDAR Mediated Signalling
    bioRxiv preprint doi: https://doi.org/10.1101/345058; this version posted June 26, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Translational regulation of Syngap1 by FMRP modulates NMDAR mediated signalling Abhik Paul1#, Bharti Nawalpuri2#, Shruthi Sateesh1, Ravi S Muddashetty2, James P Clement1* 1 Neuroscience Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064. India Phone: +91-80-22082613 2 The Institute for Stem Cell Biology and Regenerative Medicine, GKVK post, Bellary Road, Bangalore 560065. India # Equal contribution * Corresponding author: Email: [email protected] Phone: +91-80-22082613 Number of Pages: 34 including figures Number of Figure: 5 main and 4 extended Figures Number of words for: Abstract:157 Introduction: 452 Discussion: 854 Conflict of Interest: The authors declare no competing financial interests Acknowledgement: This work was supported by grants to JPC by DST-SERB (SB/YS/LS- 215/2013), and to RSM in part, by Dept. of Biotechnology, India (BT/PR8723/AGR/36/776/2013, and BT/IN/Denmark/07/RSM/2015-2016), and intramural funds from both the Institutes. We thank Bhavana Kayyar, Utsa Bhaduri, and Vijay Kumar M J for technical support in our bioinformatics analysis, and Sudhriti Ghosh Dastidar for technical advice on Figure 4. Further, we thank Dr Ravi Manjithaya and his group, and Prof. Kaustuv Sanyal’s group for technical assistance. We also thank Prof MRS Rao, Prof Tapas K Kundu, 1 bioRxiv preprint doi: https://doi.org/10.1101/345058; this version posted June 26, 2018.
    [Show full text]
  • SYNGAP1 Resource Guide
    "Building Bridges of Hope to a Cure" An Overview of SYNGAP1 Basic Biology and Clinical Description 1012 14th Street NW, Suite 500 (240) 347-0302 Washington D.C. 20005 www.bridgesyngap.org Production and distribution of this resource are made possible by an educational grant from Building Bridges of Hope to a Cure" About Us 3 Our History 4 SYNGAP1-Normal Function 5 Uniqueness in SYNGAP1 6 Common Symptoms of SYNGAP1 7 Facts about SYNGAP1 Syndrome 8 Common Indications of SYNGAP1 Cognition, development and behavior 9 Characteristics of SYNGAP1 Epilepsy 10 What About CBD? 11 SYNGAP1 Centers of Excellence 12 R e f e r e n c e s 13 References Continued 14 CBD Cited References 15 Connect with Us 16 "Building Bridges of Hope to a Cure" Bridge the Gap – SYNGAP Education and Research Foundation is the leading organization advocating and raising funds for research and treatments for SYNGAP1. The Foundation has its origins in the USA, and now with international outreach, gathers critical information from SYNGAP1 patients worldwide. Bridge the Gap-SYNGAP Education and Research Foundation's mission is to improve the quality of life for people affected by SYNGAP1, provide family support, accelerating research and raising awareness Our Mission To raise awareness and educate the public about SYNGAP1 (MRD5), unite patient families while building a robust data registry and providing meaningful information to researchers. Our Vision To increase the diagnosis rate of SYNGAP1 patients worldwide and provide the expert care, improving the quality of life for our SYNGAP1 community while searching for treatments. Our Goals Increase Diagnosis Rate will improve patient experience and quality of life a standard of care and SYNGAP1 disease profile.
    [Show full text]
  • Endogenous Sirnas and Noncoding RNA-Derived Small Rnas Are Expressed in Adult Mouse Hippocampus and Are Up-Regulated in Olfactory Discrimination Training
    Downloaded from rnajournal.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Endogenous siRNAs and noncoding RNA-derived small RNAs are expressed in adult mouse hippocampus and are up-regulated in olfactory discrimination training NEIL R. SMALHEISER,1 GIOVANNI LUGLI,1 JYOTHI THIMMAPURAM,2 EDWIN H. COOK,1 and JOHN LARSON1 1Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois 60612, USA 2W.M. Keck Center for Comparative and Functional Genomics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA ABSTRACT We previously proposed that endogenous siRNAs may regulate synaptic plasticity and long-term gene expression in the mammalian brain. Here, a hippocampal-dependent task was employed in which adult mice were trained to execute a nose-poke in a port containing one of two simultaneously present odors in order to obtain a reward. Mice demonstrating olfactory discrimination training were compared to pseudo-training and nose-poke control groups; size-selected hippocampal RNA was subjected to Illumina deep sequencing. Sequences that aligned uniquely and exactly to the genome without uncertain nucleotide assignments, within exons or introns of MGI annotated genes, were examined further. The data confirm that small RNAs having features of endogenous siRNAs are expressed in brain; that many of them derive from genes that regulate synaptic plasticity (and have been implicated in neuropsychiatric diseases); and that hairpin-derived endo-siRNAs and the 20- to 23-nt size class of small RNAs show a significant increase during an early stage of training. The most abundant putative siRNAs arose from an intronic inverted repeat within the SynGAP1 locus; this inverted repeat was a substrate for dicer in vitro, and SynGAP1 siRNA was specifically associated with Argonaute proteins in vivo.
    [Show full text]
  • Syngap Families Welcome Packet Welcome
    Syngap Families Welcome Packet Welcome We would like to extend you a warm welcome to the Syngap community. Getting a diagnosis is a big step! You finally have answers to the questions you have been asking. It could be that your child is young and you were not expecting the diagnosis… or you could have an older child and are just now finding answers after all these years. Feeling confused or overwhelmed is normal and expected. Please know that things are going to get better and we are here for you. So where do you go from here? Below are several steps we encourage you to take to learn more about Syngap. Given that Syngap is a rare neurological condition there is a great probability that your team of doctors have little or no knowledge about Syngap and how to treat it. You will soon become the Syngap specialist on your loved one’s care team and we are here to give you all the tools you need to be the best advocate. Where to start? Step 1: Basic understanding of Syngap and how it affects your loved one 1. Basic Introduction Syngap1 Syndrome is a rare genetic disorder caused by a mutation on the SYNGAP1 gene. It leads to several neurological issues in Syngap patients. Syngap1 was first diagnosed in 2009 by Dr Michaud at St Justine Hospital in Montreal. 2. Basic Genetics Syngap1 Syndrome is caused by a mutation on the SYNGAP1 gene (6p.21.32).The human body is made of trillions of cells. Each cell contains 23 pairs of chromosomes (46 total).
    [Show full text]
  • The First International Conference on SYNGAP1-Related Brain Disorders
    Weldon et al. Journal of Neurodevelopmental Disorders (2018) 10:6 DOI 10.1186/s11689-018-9225-1 REVIEW Open Access The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators Monica Weldon1, Murat Kilinc2, J. Lloyd Holder Jr3* and Gavin Rumbaugh2,4* Abstract Background: Pathologic mutations in SYNGAP1 cause a genetically defined form of intellectual disability (ID) with comorbid epilepsy and autistic features. While only recently discovered, pathogenicity of this gene is a relatively frequent genetic cause of classically undefined developmental delay that progresses to ID with commonly occurring comorbidities. Main body: A meeting of 150 people was held that included affected individuals and their caregivers, clinicians that treat this and related brain disorders, neuroscientists that study SYNGAP1 biology or the function of related genes, and representatives from government agencies that fund science and approve new medical treatments. The meeting focused on developing a consensus among all stakeholders as to how best to achieve a more fundamental and profound understanding of SYNGAP1 biology and its role in human disease. Short conclusion: From all of these proceedings, several areas of consensus emerged. The clinicians and geneticists agreed that the prevalence of epilepsy and sensory processing impairments in SYNGAP1-related brain disorders approached 100%. The neurobiologists agreed that more basic research is needed to better understand the molecular and cellular functions of the Syngap1 gene, which will lead to targets for therapeutic intervention. Finally, everyone agreed that there is a pressing need to form a robust patient registry as an initial step toward a prospective natural history study of patients with pathogenic SYNGAP1 variants.
    [Show full text]
  • Characterization of Intellectual Disability and Autism Comorbidity Through Gene Panel Sequencing
    bioRxiv preprint doi: https://doi.org/10.1101/545772; this version posted February 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Characterization of Intellectual disability and Autism comorbidity through gene panel sequencing Maria Cristina Aspromonte 1, 2, Mariagrazia Bellini 1, 2, Alessandra Gasparini 3, Marco Carraro 3, Elisa Bettella 1, 2, Roberta Polli 1, 2, Federica Cesca 1, 2, Stefania Bigoni 4, Stefania Boni 5, Ombretta Carlet 6, Susanna Negrin 6, Isabella Mammi 7, Donatella Milani 8 , Angela Peron 9, 10, Stefano Sartori 11, Irene Toldo 11, Fiorenza Soli 12, Licia Turolla 13, Franco Stanzial 14, Francesco Benedicenti 14, Cristina Marino-Buslje 15, Silvio C.E. Tosatto 3, 16, Alessandra Murgia 1, 2, Emanuela Leonardi 1, 2 1. Molecular Genetics of Neurodevelopment, Dept. of Woman and Child Health, University of Padova, Padova, Italy 2. Fondazione Istituto di Ricerca Pediatrica (IRP), Città della Speranza, Padova, Italy 3. Dept. of Biomedical Sciences, University of Padova, Padova, Italy 4. Medical Genetics Unit, Ospedale Universitario S. Anna, Ferrara, Italy 5. Medical Genetics Unit, S. Martino Hospital, Belluno, Italy 6. Child Neuropsychiatry Unit, IRCCS Eugenio Medea, Conegliano, Italy 7. Medical Genetics Unit, Dolo General Hospital, Venezia, Italy 8. Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, University of Milano, Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy 9. Child Neuropsychiatry Unit, Epilepsy Center, Santi Paolo-Carlo Hospital, Dept. of Health Sciences, University of Milano, Milano, Italy 10. Department of Pediatrics, Division of Medical Genetics, University of Utah School of Medicine, Salt Lake City, UT, USA 11.
    [Show full text]
  • Twenty Years of Syngap Research: from Synapses to Cognition
    1596 • The Journal of Neuroscience, February 19, 2020 • 40(8):1596–1605 Review Twenty Years of SynGAP Research: From Synapses to Cognition X Timothy R. Gamache,1,2 XYoichi Araki,1,2 and XRichard L. Huganir1,2 1Solomon H. Snyder Department of Neuroscience, and 2Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, Maryland 21205 SynGAP is a potent regulator of biochemical signaling in neurons and plays critical roles in neuronal function. It was first identified in 1998, and has since been extensively characterized as a mediator of synaptic plasticity. Because of its involvement in synaptic plasticity, SynGAP has emergedasacriticalproteinfornormalcognitivefunction.Inrecentyears,mutationsintheSYNGAP1genehavebeenshowntocauseintellectual disabilityinhumansandhavebeenlinkedtootherneurodevelopmentaldisorders,suchasautismspectrumdisordersandschizophrenia.While the structure and biochemical function of SynGAP have been well characterized, a unified understanding of the various roles of SynGAP at the synapse and its contributions to neuronal function remains to be achieved. In this review, we summarize and discuss the current understanding of the multifactorial role of SynGAP in regulating neuronal function gathered over the last two decades. Introduction SynGAP structure and function SynGAP was first identified, cloned, and characterized in 1998 by SynGAP is an exceedingly abundant constituent of the PSD. In- two independent laboratories (Chen et al., 1998; Kim et al., deed, quantitative proteomic analyses have revealed SynGAP to 1998). One study identified SynGAP following a yeast two-hybrid be one of the most highly abundant proteins in the PSD, reaching screen for novel PDZ-interacting proteins. The screen specifically copy numbers that are surpassed only by CaMKII␣ and the identified proteins from a hippocampal cDNA library that inter- PSD-95 family proteins (Sugiyama et al., 2005; Cheng et al., 2006; act with the third PDZ domain of SAP102, a member of the Sheng and Kim, 2011).
    [Show full text]
  • Tiratha Raj Singh.Pdf
    GENE-40307; No. of pages: 10; 4C: Gene xxx (2015) xxx–xxx Contents lists available at ScienceDirect Gene journal homepage: www.elsevier.com/locate/gene 1Q1 Unc-51 like kinase 1 (ULK1) in silico analysis for biomarker 2 identification: A vital component of autophagy 3Q2 Rohit Randhawa a, Manika Sehgal a, Tiratha Raj Singh a, Ajay Duseja b, Harish Changotra a,⁎ 4 a Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan 1732 34 Himachal Pradesh, India 5 b Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India 6 article info abstract 7 Article history: Autophagy is a degradation pathway involving lysosomal machinery for degradation of damaged organelles like 19 8 Received 19 October 2014 the endoplasmic reticulum and mitochondria into their building blocks to maintain homeostasis within the cell. 20 9 Received in revised form 3 February 2015 ULK1, a serine/threonine kinase, is conserved across species, from yeasts to mammals, and plays a central role in 21 10 Accepted 5 February 2015 autophagy pathway. It receives signals from upstream modulators such as TIP60, mTOR and AMPK and relays 22 11 Available online xxxx them to its downstream substrates like Ambra1 and ZIP kinase. The activity of this complex is regulated through 23 – fi fi 24 12 Keywords: protein protein interactions and post-translational modi cations. Applying in silico analysis we identi ed 25 13Q3 Autophagy (i) conserved patterns of ULK1 that showed its evolutionary relationship between the species which were closely 14 ULK1 related in a family compared to others.
    [Show full text]
  • SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons
    7980 • The Journal of Neuroscience, October 7, 2020 • 40(41):7980–7994 Neurobiology of Disease SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons Nerea Llamosas,1 Vineet Arora,1 Ridhima Vij,2,3 Murat Kilinc,1 Lukasz Bijoch,4 Camilo Rojas,1 Adrian Reich,5 BanuPriya Sridharan,6 Erik Willems,7 David R. Piper,7 Louis Scampavia,6 Timothy P. Spicer,6 Courtney A. Miller,1,6 J. Lloyd Holder,2,3 and Gavin Rumbaugh1 1Department of Neuroscience, Scripps Research, Jupiter, Florida 33458, 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas 77030, 3Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, 4Laboratory of Neurobiology, BRAINCITY, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland, 5Center for Computational Biology and Bioinformatics, Scripps Research, Jupiter, Florida 33458, 6Department of Molecular Medicine, Scripps Research, Jupiter, Florida 33458, and 7Cell Biology, Thermo Fisher Scientific, Carlsbad, California 92008 SYNGAP1 is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. De novo loss-of-function variants in this gene cause a neurodevelopmental disorder defined by cognitive impairment, social-communica- tion disorder, and early-onset seizures. Cell biological studies in mouse and rat neurons have shown that Syngap1 regulates developing excitatory synapse structure and function, with loss-of-function variants driving formation of larger dendritic spines and stronger glu- tamatergic transmission. However, studies to date have been limited to mouse and rat neurons. Therefore, it remains unknown how SYNGAP1 loss of function impacts the development and function of human neurons.
    [Show full text]
  • SYNGAP1: Mind the Gap
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 15 February 2016 doi: 10.3389/fncel.2016.00032 SYNGAP1: Mind the Gap Nallathambi Jeyabalan 1 and James P. Clement 2* 1 Narayana Nethralaya Post-Graduate Institute of Ophthalmology, Narayana Nethralaya Foundation, Narayana Health City, Bangalore, India, 2 Neuroscience Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India A cardinal feature of early stages of human brain development centers on the sensory, cognitive, and emotional experiences that shape neuronal-circuit formation and refinement. Consequently, alterations in these processes account for many psychiatric and neurodevelopmental disorders. Neurodevelopment disorders affect 3–4% of the world population. The impact of these disorders presents a major challenge to clinicians, geneticists, and neuroscientists. Mutations that cause neurodevelopmental disorders are commonly found in genes encoding proteins that regulate synaptic function. Investigation of the underlying mechanisms using gain or loss of function approaches has revealed alterations in dendritic spine structure, function, and plasticity, consequently modulating the neuronal circuit formation and thereby raising the possibility of neurodevelopmental disorders resulting from synaptopathies. One such gene, SYNGAP1 (Synaptic Ras-GTPase-activating protein) has been shown to cause Intellectual Disability (ID) with comorbid Autism Spectrum Disorder (ASD) and epilepsy in children. SYNGAP1 is a negative regulator of Ras, Rap and of AMPA receptor trafficking to the postsynaptic membrane, thereby regulating not only synaptic plasticity, but also neuronal homeostasis. Recent studies on the neurophysiology of SYNGAP1, using Syngap1 mouse models, have provided deeper insights into how downstream signaling proteins and synaptic plasticity are regulated by SYNGAP1.
    [Show full text]
  • Syngap Splice Isoforms Differentially Regulate Synaptic Plasticity and Dendritic Development
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.28.922013; this version posted January 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Regulation of neuronal function by distinct SynGAP isoforms Araki Y and Huganir RL et al SynGAP splice isoforms differentially regulate synaptic plasticity and dendritic development Yoichi Araki, Ingie Hong, Timothy R. Gamache, Shaowen Ju, Leonardo Collado-Torres+, Joo Heon Shin+, and Richard L. Huganir 1. Johns Hopkins University School of Medicine Department of Neuroscience Kavli Neuroscience Discovery Institute 2+. Lieber Institute for Brain Development Correspondence: [email protected] Keywords: Synaptic plasticity, Synaptic GTPase activating protein, Liquid-liquid phase separation, Dendritic development 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.28.922013; this version posted January 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Regulation of neuronal function by distinct SynGAP isoforms Araki Y and Huganir RL et al Highlights 1. SynGAP-α1, α2, β, γ isoforms have distinct spatiotemporal expression and function in the brain. 2. SynGAP-α1 is required for plasticity, while β is required for dendritic development. 3. Liquid-liquid phase separation of SynGAP-α1 is required for its role in plasticity.
    [Show full text]